Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.

ABSTRACT:

Background

Myocarditis and pericarditis cases following Coronavirus 2019 (COVID-19) vaccination were reported worldwide. In Thailand, COVID-19 vaccines were approved for emergency use. Adverse event following immunization (AEFI) surveillance has been strengthened to ensure the safety of the vaccines. This study aimed to describe the characteristics of myocarditis and pericarditis, and identify the factors associated with myocarditis and pericarditis following COVID-19 vaccination in Thailand.

Method

We carried out a descriptive study of reports of myocarditis and pericarditis to Thailand's National AEFI Program (AEFI-DDC) between 1 March and 31 December 2021. An unpaired case-control study was conducted to determine the factors associated with myocarditis and pericarditis af

SUBMITTER: Mahasing C 

PROVIDER: S-EPMC10141407 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature